Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma by Loriot, Yohann, Sternberg, Cora N., Castellano, Daniel, Oosting, Sjoukje F., Dumez, Herlinde, Huddart, Robert, Vianna, Karina, Alonso Gordoa, Teresa, Skoneczna, Iwona, Fay, Andre P., Nolè, Franco, Massari, Francesco, Brasiuniene, Birute, Maroto, Pablo, Fear, Simon, Di Nucci, Flavia, de Ducla, Sabine, Choy, Ernest

Get full text

Abstract CT159: CYCLONE 1: abemaciclib in men with heavily pretreated metastatic castration-resistant prostate cancer (mCRPC) by Agarwal, Neeraj, Guana, Daniel Castellano, Gordoa, Teresa A., Arija, Jose A., Colomba, Emeline, Gravis, Gwenaelle, Mourey, Loic, Oudard, Stephanie, Flechon, Aude, Gonzalez, Macarena, Maroto-Rey, Pablo, Schweizer, Michael, Gallardo, Enrique, Nacerddine, Karim, Appiach, Adams K., Balar, Arjun, Johnston, Erica, Piulats, José M.

Get full text

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open... by Choueiri, Toni K, Eto, Masatoshi, Motzer, Robert, De Giorgi, Ugo, Buchler, Tomas, Basappa, Naveen S, Méndez-Vidal, María José, Tjulandin, Sergei, Hoon Park, Se, Melichar, Bohuslav, Hutson, Thomas, Alemany, Carlos, McGregor, Bradley, Powles, Thomas, Grünwald, Viktor, Alekseev, Boris, Rha, Sun Young, Kopyltsov, Evgeny, Kapoor, Anil, Alonso Gordoa, Teresa, Goh, Jeffrey C, Staehler, Michael, Merchan, Jaime R, Xie, Ran, Perini, Rodolfo F, Mody, Kalgi, McKenzie, Jodi, Porta, Camillo G

Get full text

Multimodal approach to the treatment of patients with radioiodine refractory differentiated thyroid cancer and metastases to the central nervous system by Alonso‐Gordoa, Teresa

Get full text

Tumor‐associated macrophages: “Good cop‐bad cop” by Molina‐Cerrillo, Javier, Alonso‐Gordoa, Teresa, Garrido, Pilar

Get full text

The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE‐1407) by Grande, Enrique, Teulé, Alex, Alonso‐Gordoa, Teresa, Jiménez‐Fonseca, Paula, Benavent, Marta, Capdevila, Jaume, Custodio, Ana, Vera, Ruth, Munarriz, Javier, La Casta, Adelaida, Díez, Juan José, Gajate, Pablo, Molina‐Cerrillo, Javier, Matos, Ignacio, Cristóbal, Eva María, Ruffinelli, José C., Palacios, José, García‐Carbonero, Rocío

Get full text

Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long‐Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor by Molina‐Cerrillo, Javier, Grande, Enrique, Alonso‐Gordoa, Teresa

Get full text

A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide by Fernandez‐Perez, María P., Perez‐Navarro, Enrique, Alonso‐Gordoa, Teresa, Conteduca, Vicenza, Font, Albert, Vázquez‐Estévez, Sergio, González‐del‐Alba, Aránzazu, Wetterskog, Daniel, Antonarakis, Emmanuel S., Mellado, Begona, Fernandez‐Calvo, Ovidio, Méndez‐Vidal, María J., Climent, Miguel A., Duran, Ignacio, Gallardo, Enrique, Rodriguez Sanchez, Angel, Santander, Carmen, Sáez, Maria I., Puente, Javier, Tudela, Julian, Martínez, Alberto, López‐Andreo, Maria J., Padilla, José, Lozano, Rebeca, Hervas, David, Luo, Jun, Giorgi, Ugo, Castellano, Daniel, Attard, Gerhardt, Grande, Enrique, Gonzalez‐Billalabeitia, Enrique

Get full text

Tyrosine Kinase Receptors in Oncology by Esteban-Villarrubia, Jorge, Soto-Castillo, Juan José, Pozas, Javier, San Román-Gil, María, Orejana-Martín, Inmaculada, Torres-Jiménez, Javier, Carrato, Alfredo, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier

Get full text

Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours by Dawod, Mohammed, Gordoa, Teresa Alonso, Cives, Mauro, De Mestier, Louis, Crona, Joakim, Spada, Francesca, Oberg, Kjel, Pavel, Marianne, Lamarca, Angela

Get full text

Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys" by Alonso-Gordoa, Teresa, García-Bermejo, María Laura, Grande, Enrique, Garrido, Pilar, Carrato, Alfredo, Molina-Cerrillo, Javier

Get full text

Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki‐67 Is ≥10%? by Merola, Elettra, Alonso Gordoa, Teresa, Zhang, Panpan, Al‐Toubah, Taymeyah, Pellè, Eleonora, Kolasińska‐Ćwikła, Agnieszka, Zandee, Wouter, Laskaratos, Faidon, Mestier, Louis, Lamarca, Angela, Hernando, Jorge, Cwikla, Jaroslaw, Strosberg, Jonathan, Herder, Wouter, Caplin, Martin, Cives, Mauro, Leeuwaarde, Rachel

Get full text

Sunitinib and Evofosfamide (TH‐302) in Systemic Treatment‐Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE‐1408 Trial by Grande, Enrique, Rodriguez‐Antona, Cristina, López, Carlos, Alonso‐Gordoa, Teresa, Benavent, Marta, Capdevila, Jaume, Teulé, Alex, Custodio, Ana, Sevilla, Isabel, Hernando, Jorge, Gajate, Pablo, Molina‐Cerrillo, Javier, Díez, Juan José, Santos, María, Lanillos, Javier, García‐Carbonero, Rocío

Get full text

Adipose tissue compartments, muscle mass, muscle fat infiltration, and coronary calcium in institutionalized frail nonagenarians by Idoate, Fernando, Cadore, Eduardo L., Casas-Herrero, Alvaro, Zambom-Ferraresi, Fabricio, Marcellán, Teresa, de Gordoa, Ana Ruiz, Rodriguez-Mañas, Leocadio, Bastarrika, Gorka, Marques, Mário C., Martínez-Velilla, Nicolas, Vicente-Campos, Davinia, Izquierdo, Mikel

Get full text

Clinical outcome after progressing to frontline and second-line Anti–PD-1/PD-L1 in advanced urothelial cancer by Gómez de Liaño Lista, Alfonso, van Dijk, Nick, de Velasco Oria de Rueda, Guillermo, Necchi, Andrea, Lavaud, Pernelle, Morales-Barrera, Rafael, Alonso Gordoa, Teresa, Maroto, Pablo, Ravaud, Alain, Durán, Ignacio, Szabados, Bernadett, Castellano, Daniel, Giannatempo, Patrizia, Loriot, Yohann, Carles, Joan, Anguera Palacios, Georgia, Lefort, Felix, Raggi, Daniele, Gross Goupil, Marine, Powles, Thomas, Van der Heijden, Michiel S.

Get full text

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial by Powles, Thomas, Oudard, Stephane, Vulsteke, Christof, Fléchon, Aude, Yu, Evan Y, Imai, Kentaro, Homet Moreno, Blanca, Alva, Ajjai, Lazzaro, Mauricio Fernandez, Gatica, Gabriela, Van Aelst, Filip, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Soares, Joao Paulo Holanda, Cheng, Susanna, Leal, Jose Luis, Ibanez, Carolina, Laguerre, Brigitte, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Gravis, Gwenaelle, Reichardt, Peter, Herden, Jan, Pfister, David, Niegisch, Guenter, Boegemann, Martin, Gakis, Georgios, Neisius, Andreas, Thomas, Christian, Kosa, Judit Erzsebet, Bodoky, Gyorgy, Geczi, Lajos, Frank, Stephen Jay, Kejzman, Daniel, Rosenbaum, Eli, Rouvinov, Keren, Arai, Gaku, Takayama, Tatsuya, Fujimoto, Kiyohide, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Takano, Toshimi, Joraku, Akira, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Beerepoot, Laurens, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Karlov, Petr Alexandrovich, Cohen, Graham Lawrence, Ruff, Paul, Lee, Nari, Rodriguez-Vida, Alejo, Grande, Enrique, Munoz Langa, Jose, Montesa Pino, Alvaro, Su, Wen-Pin, Chang, Yen-Hwa, Huang, Yi-Hsiu, Srimuninnimit, Vichien, Abali, Huseyin, Sendur, Mehmet Ali Nahit, Ozguroglu, Mustafa, Ozdogan, Mustafa, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Schlegel, Peter, Mamtani, Ronac, Wallace, James, Suh, Jason Jung-Gon, Burgess, Earle, Wong, John, Chaudhry, Arvind, Thomas, Christian A, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Joshi, Monika, Bolemon, Britt H, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Courtright, Jay G, Doshi, Gurjyot, Sartor, Oliver Alton, Mannuel, Heather D, Alva, Ajjai, Charles, Anthony, Ades, Steven, Yu, Evan, Fleming, Mark

Get full text

Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy by Martínez-Sáez, Olga, Borau, Pablo Gajate, Alonso-Gordoa, Teresa, Molina-Cerrillo, Javier, Grande, Enrique

Get full text

Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial by Rha, Sun Young, Choueiri, Toni K., Matveev, Vsevolod B., Alyasova, Anna, Hong, Sung‐Hoo, Gordoa, Teresa Alonso, Gurney, Howard, Bjarnason, Georg A., Buchler, Tomas, Pedrazzoli, Paolo, Takagi, Toshio, Park, Se Hoon, Lee, Jae Lyun, Perini, Rodolfo F., He, Cixin S., McKenzie, Jodi A., Eto, Masatoshi

Get full text

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study) by Solis-Hernandez, Mª Pilar, Fernandez del Valle, Ana, Carmona-Bayonas, Alberto, Garcia-Carbonero, Rocio, Custodio, Ana, Benavent, Marta, Alonso Gordoa, Teresa, Nuñez-Valdovino, Bárbara, Sanchez Canovas, Manuel, Matos, Ignacio, Alonso, Vicente, Lopez, Carlos, Viudez, Antonio, Izquierdo, Marta, Calvo-Temprano, David, Grande, Enrique, Capdevila, Jaume, Jimenez-Fonseca, Paula

Get full text

Addendum: Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation by Molina-Cerrillo, Javier, Alonso-Gordoa, Teresa, Carrato, Alfredo, Grande, Enrique

Get full text